TCTR20190417004已完成4 期
The effect of the low-dose spironolactone in post adolescent acne: a randomized, double-blind, placebo-controlled trial.
Faculty of Medicine, Chulalongkorn University0 个研究点目标入组 62 人开始时间: 2019年4月17日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 62
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 25 Years 至 45 Years（—）
- 性别
- Female
入选标准
- •healty female with moderate degree acne age from 25-45 years old
- •no underlying hepatic or renal dysfuncions
- •no current topical or systemic medications which can aggrating or suppressing acne condition
排除标准
- •patients who are preganacy or lactating.
- •patients who are suspected of polycystic ovarian diseases or other abnormalities predisposing to acne conditions.
- •patients with abnormal skin conditions on their face
研究者
相似试验
已完成
2 期
The Effect of Spironolactone in Treatment of Essential HypertensioHypertension.Essential (primary) hypertensionIRCT201502011525N6Shiraz University of Midical Sciences40
已完成
3 期
Effect of Spirnolactone in heart failureHeart failure.congestive heart failureIRCT2015010520563N1Ahwaz Jundishapur University of Medical Science100
已完成
不适用
combination therapy trial in COVID-19 patientsCOVID19.COVID-19, virus identifiedU07.1IRCT20201003048904N2Boushehr University of Medical Sciences200
已完成
2 期
The effect of spironolactone in treatment of heart failureHeart Failure.Congestive heart failureIRCT2015101924597N1Vice chancellor for research of Iran university of medical sciences60
招募中
2 期
Comparing the effectiveness of spironolactone solution with clindamycin solution in patients with acneMild to moderate acne vulgaris.Acne vulgarisL70.0IRCT20120524009844N12Tabriz University of Medical Sciences60